Shiwali Rai, MD
Family Medicine · Dallas, TXNPI 1346283090
Payments from drug & device makers
Across 181 payments — averaging $15,434 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$731K
- Roche Molecular Systems, Inc.$690K
- Quidel Corporation$407K
- Visby Medical, Inc.$313K
- Diasorin Molecular LLC$195K
- Covis Pharma GmbH$159K
- plus $300K from 12 others
Across 1 payment — averaging $27,009 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- BD$27K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 24 | $730,638 |
| Roche Molecular Systems, Inc. | 57 | $689,845 |
| Quidel Corporation | 20 | $406,975 |
| Visby Medical, Inc. | 19 | $312,675 |
| Diasorin Molecular LLC | 1 | $194,821 |
| Covis Pharma GmbH | 2 | $158,631 |
| Evofem Biosciences, Inc. | 11 | $55,115 |
| BD | 8 | $44,054 |
| Pfizer | 10 | $43,909 |
| Cepheid | 5 | $37,500 |
| Genentech, Inc. | 6 | $36,291 |
| Partner Therapeutics, Inc. | 4 | $29,623 |
| Cue Health Inc. | 1 | $18,458 |
| GSK | 6 | $18,324 |
| Rapid Pathogen Screening, Inc. | 3 | $10,600 |
| Orasure Technologies Inc. | 2 | $6,000 |
| Genentech USA, Inc. | 1 | $18 |
| AstraZeneca | 1 | $15 |
How this compares
$2,793,492 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Dallas
- Thomas KingDallas$12M
- Jennifer ZonDallas$5.9M
- Chrisette DharmagunaratneDallas$5.6M
- Michele ReynoldsDallas$3.8M
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.